SCR-0265096

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameSCR-0265096
Drug Alias NameMAPKAP2 nuclear translocation inhibitors (BioImage)SCR-0334652SCR-0334684SCR-0334687SCR-0335186 +[21] 
ClassificationSmall molecules
Mechanisms of ActionMAP kinase-activated protein kinase 2 inhibitorsP38 α mitogen-activated protein kinase inhibitors
TargetsMAP kinase-activated protein kinase 2P38 α mitogen-activated protein kinase
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBioImage AS
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBioImage AS
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A